Combination of Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin and Angiotensin-II Receptor Blocker, Varsartan Ameliorates Both Insulin Insufficiency and Insulin Resistance in Mouse Models of Type 2 Diabetes

被引：0
|
作者：
Miyagawa, Katsutoshi
Kondo, Tatsuya
Matsuyama, Rina
Goto, Rieko
Kawashima, Junji
Motoshima, Hiroyuki
Araki, Eiichi
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1879-P
引用
收藏
页码：A482 / A482
页数：1
相关论文
共 26 条
  • [21] Effects of SYR-322, a novel inhibitor of dipeptidyl peptidase-IV, alone or in combination with pioglitazone in obese and non-obese type 2 diabetes model rats and mice
    Takeuchi, Koji
    Moritoh, Yusuke
    Asakawa, Tomoko
    Kataoka, Osamu
    Zhang, Zhiyuan
    Odaka, Hiroyuki
    DIABETES, 2006, 55 : A465 - A465
  • [22] Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan
    Guo, Li Li
    Pan, Yu
    Jin, Hui Min
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 1876 - 1883
  • [23] Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
    Yuichi Terawaki
    Chikayo Iwaya
    Takashi Nomiyama
    Dai Shimono
    Tsuyoshi Horikawa
    Yuki Fujimura-Tanaka
    Toru Shigeoka
    Nobuya Hamanoue
    Ryoko Motonaga
    Makito Tanabe
    Toshihiko Yanase
    Daiji Kawanami
    Diabetology International, 2020, 11 : 274 - 282
  • [24] Efficacy and safety of a combination of an insulin secretagogue and a dipeptidyl peptidase-4 inhibitor in Japanese patients with type 2 diabetes mellitus; the repaglinide glucose oscillation study in Fukuoka (REGO-F)
    Terawaki, Yuichi
    Iwaya, Chikayo
    Nomiyama, Takashi
    Shimono, Dai
    Horikawa, Tsuyoshi
    Fujimura-Tanaka, Yuki
    Shigeoka, Toru
    Hamanoue, Nobuya
    Motonaga, Ryoko
    Tanabe, Makito
    Yanase, Toshihiko
    Kawanami, Daiji
    DIABETOLOGY INTERNATIONAL, 2020, 11 (03) : 274 - 282
  • [25] 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance
    Xu, Hong-Zhao
    Cheng, Yan-Li
    Wang, Wan-Ning
    Wu, Hao
    Zhang, Yuan-Yuan
    Zang, Chong-Sen
    Xu, Zhong-Gao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [26] Combination of the Dipeptidyl Peptidase IV Inhibitor LAF237 [(S)-1-[(3-Hydroxy-1-adamantyl)ammo]acetyl-2-cyano-pyrrolidine] with the Angiotensin II Type 1 Receptor Antagonist Valsartan [N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-L-valine] Enhances Pancreatic Islet Morphology and Function in a Mouse Model of Type 2 Diabetes
    Cheng, Qianni
    Law, Pui Ki
    de Gasparo, Marc
    Leung, Po Sing
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (03): : 683 - 691
123